Evolution of the Average Target: Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

1f34d910bcf10f791c9ec66bbfe.Gu3eIG9WsjhZ0V-7QcSgMGv1fqez9pM4msn0GWnKYGc.aIStFjUv7XsV4TvJKfPMXT69U57wp9BL_5y4S1GwMV5ompN2AWCDTTy7Fg~48d67871337f3f8fabbb3d823830d8e6
01/08 Stride Shares Fall After William Blair Downgrade MT
31/07 William Blair Downgrades Stride to Market Perform From Outperform MT
29/10/25 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
29/10/25 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
06/10/25 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
29/08/25 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
06/08/25 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
06/08/25 Stride Q4 revenue, adjusted EPS beat estimates RE
30/04/25 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
30/04/25 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
22/04/25 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
21/04/25 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
30/01/25 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
23/10/24 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
21/08/24 Stride Shares Fall After Citigroup Downgrade MT
20/08/24 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
08/08/24 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
08/08/24 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
31/07/24 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24/04/24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
26/01/24 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
25/01/24 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
25/01/24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
17/11/23 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
17/11/23 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+40.08%
+37.99%
+10.26%
+20.93%
+34.2%
+15.18%
+30.27%
- - +38.02%
+36.29%
Average +29.25%
Weighted average by Cap. +29.60%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
83.67USD
Average target price
109.00USD
Spread / Average Target
+30.27%
High Price Target
125.00USD
Spread / Highest target
+49.40%
Low Price Target
93.00USD
Spread / Lowest Target
+11.15%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

William Blair & Co.
BMO Capital
Morgan Stanley
Barrington Research
Citigroup
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
83.67USD
Average target price
109.00USD
Spread / Average Target
+30.27%

Quarterly revenue - Rate of surprise